Is restricted fetal growth associated with later adiposity? Observational analysis of a randomized trial

Michael S Kramer1, Richard M Martin1, Natalia Bogdanovich1

  • 1From the Departments of Pediatrics (MSK and MD) and Epidemiology, Biostatistics and Occupational Health (MSK), McGill University Faculty of Medicine, Montreal, Canada; the School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom (RMM); the National Institute for Health Research, Bristol Biomedical Research Unit in Nutrition, Bristol, United Kingdom (RMM); State Institution "the Republican Scientific and Practical Centre Mother and Child," Ministry of Health, Republic of Belarus (NB and KV); and the Obesity Prevention Program, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA (EO).

Insights

Children born small for gestational age (SGA) were shorter, thinner, and had less body fat at age 11.5 years than peers. Postnatal weight gain did not alter these long-term adiposity differences in SGA children.

Area of Science:

  • Pediatric endocrinology
  • Growth and development
  • Public health nutrition

Background:

  • Developmental origins research suggests small for gestational age (SGA) birth increases long-term adiposity risks.
  • Truncal adiposity is a particular concern in children born SGA.

Purpose of the Study:

  • To evaluate the impact of SGA birth and early infancy weight gain on adiposity at 11.5 years of age.
  • To compare adiposity markers in children born SGA, LGA, and AGA.

Main Methods:

  • Utilized data from 17,046 Belarusian children in a cluster-randomized breastfeeding promotion trial.
  • Measured height, weight, circumferences, skinfolds, and body fat percentage at 11.5 years.
  • Employed multilevel statistical models controlling for various covariates.

Main Results:

  • Children born SGA exhibited significantly lower BMI, body fat percentage, and fat mass index compared to AGA peers.
  • A dose-response effect was observed across SGA subcategories.
  • SGA infants with early catch-up growth had intermediate growth and adiposity measures.
  • Children born LGA showed opposite effects of similar magnitude.

Conclusions:

  • At 11.5 years, Belarusian children born SGA were shorter, thinner, and had less body fat than non-SGA peers.
  • These differences persisted irrespective of postnatal weight gain.
  • Findings contribute to understanding long-term health outcomes related to fetal growth.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
2.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368